- Home
- STN vs QGEN Comparison
STN vs QGEN Comparison
Compare STN & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STN
- QGEN
- Stock Information
- Founded
- STN 1954
- QGEN 1986
- Country
- STN Canada
- QGEN Netherlands
- Employees
- STN N/A
- QGEN N/A
- Industry
- STN Military/Government/Technical
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- STN Consumer Discretionary
- QGEN Health Care
- Exchange
- STN Nasdaq
- QGEN Nasdaq
- Market Cap
- STN 12.6B
- QGEN 10.3B
- IPO Year
- STN N/A
- QGEN 1996
- Fundamental
- Price
- STN $110.50
- QGEN $46.80
- Analyst Decision
- STN
- QGEN Buy
- Analyst Count
- STN 0
- QGEN 8
- Target Price
- STN N/A
- QGEN $51.01
- AVG Volume (30 Days)
- STN 205.2K
- QGEN 1.1M
- Earning Date
- STN 11-06-2025
- QGEN 11-05-2025
- Dividend Yield
- STN 0.41%
- QGEN 3.23%
- EPS Growth
- STN 29.73
- QGEN 405.09
- EPS
- STN 2.80
- QGEN 1.69
- Revenue
- STN $4,511,386,797.00
- QGEN $2,040,067,000.00
- Revenue This Year
- STN $12.45
- QGEN $7.37
- Revenue Next Year
- STN $10.34
- QGEN $5.70
- P/E Ratio
- STN $39.38
- QGEN $27.64
- Revenue Growth
- STN 13.47
- QGEN 5.15
- 52 Week Low
- STN $73.18
- QGEN $37.63
- 52 Week High
- STN $113.50
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- STN 55.93
- QGEN 55.40
- Support Level
- STN $105.45
- QGEN $43.74
- Resistance Level
- STN $107.96
- QGEN $46.23
- Average True Range (ATR)
- STN 1.92
- QGEN 0.67
- MACD
- STN 0.11
- QGEN 0.26
- Stochastic Oscillator
- STN 75.94
- QGEN 97.14
About STN Stantec Inc
Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).